223 related articles for article (PubMed ID: 36726154)
1. Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model.
Kim H; Noh M; Zhang H; Kim Y; Park S; Park J; Kwon YG
Fluids Barriers CNS; 2023 Feb; 20(1):9. PubMed ID: 36726154
[TBL] [Abstract][Full Text] [Related]
2. CU06-1004 (endothelial dysfunction blocker) ameliorates astrocyte end-feet swelling by stabilizing endothelial cell junctions in cerebral ischemia/reperfusion injury.
Kim DY; Zhang H; Park S; Kim Y; Bae CR; Kim YM; Kwon YG
J Mol Med (Berl); 2020 Jun; 98(6):875-886. PubMed ID: 32415357
[TBL] [Abstract][Full Text] [Related]
3. CU06-1004 enhances vascular integrity and improves cardiac remodeling by suppressing edema and inflammation in myocardial ischemia-reperfusion injury.
Zhang H; Kim H; Park BW; Noh M; Kim Y; Park J; Park JH; Kim JJ; Sim WS; Ban K; Park HJ; Kwon YG
Exp Mol Med; 2022 Jan; 54(1):23-34. PubMed ID: 34997212
[TBL] [Abstract][Full Text] [Related]
4. The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
Bae CR; Zhang H; Kwon YG
PLoS One; 2020; 15(12):e0243497. PubMed ID: 33275637
[TBL] [Abstract][Full Text] [Related]
5. GKT136901 protects primary human brain microvascular endothelial cells against methamphetamine-induced blood-brain barrier dysfunction.
Hwang JS; Cha EH; Ha E; Park B; Seo JH
Life Sci; 2020 Sep; 256():117917. PubMed ID: 32525001
[TBL] [Abstract][Full Text] [Related]
6. CU06-1004 alleviates vascular hyperpermeability in a murine model of hereditary angioedema by protecting the endothelium.
Lee S; Kim Y; Kim YS; Zhang H; Noh M; Kwon YG
Allergy; 2023 May; 78(5):1333-1346. PubMed ID: 36789476
[TBL] [Abstract][Full Text] [Related]
7. Vascular Cell Senescence Contributes to Blood-Brain Barrier Breakdown.
Yamazaki Y; Baker DJ; Tachibana M; Liu CC; van Deursen JM; Brott TG; Bu G; Kanekiyo T
Stroke; 2016 Apr; 47(4):1068-77. PubMed ID: 26883501
[TBL] [Abstract][Full Text] [Related]
8. CU06-1004 alleviates oxidative stress and inflammation on folic acid-induced acute kidney injury in mice.
Bae CR; Kim Y; Kwon YG
J Pharmacol Sci; 2024 Feb; 154(2):77-85. PubMed ID: 38246731
[TBL] [Abstract][Full Text] [Related]
9. FGF21 Protects against Aggravated Blood-Brain Barrier Disruption after Ischemic Focal Stroke in Diabetic db/db Male Mice via Cerebrovascular PPARγ Activation.
Jiang Y; Lin L; Liu N; Wang Q; Yuan J; Li Y; Chung KK; Guo S; Yu Z; Wang X
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012810
[TBL] [Abstract][Full Text] [Related]
10. CU06-1004 as a promising strategy to improve anti-cancer drug efficacy by preventing vascular leaky syndrome.
Park S; Lee S; Kim D; Kim H; Kwon YG
Front Pharmacol; 2023; 14():1242970. PubMed ID: 37711172
[No Abstract] [Full Text] [Related]
11. CU06-1004 Alleviates Experimental Colitis by Modulating Colonic Vessel Dysfunction.
Kim YS; Zhang H; Lee S; Park S; Noh M; Kim YM; Kwon YG
Front Pharmacol; 2020; 11():571266. PubMed ID: 33041812
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of CU06-1004 attenuates vascular permeability and stabilizes neovascularization in retinal vascular diseases.
Noh M; Kim Y; Zhang H; Kim H; Bae CR; Lee S; Kwon YG
Eur J Pharmacol; 2023 Jan; 939():175427. PubMed ID: 36509133
[TBL] [Abstract][Full Text] [Related]
13. Decline in Sirtuin-1 expression and activity plays a critical role in blood-brain barrier permeability in aging.
Stamatovic SM; Martinez-Revollar G; Hu A; Choi J; Keep RF; Andjelkovic AV
Neurobiol Dis; 2019 Jun; 126():105-116. PubMed ID: 30196051
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen in mice cerebral microvessels induces blood-brain barrier dysregulation with aging via a dynamin-related protein 1-dependent pathway.
Chandra PK; Panner Selvam MK; Castorena-Gonzalez JA; Rutkai I; Sikka SC; Mostany R; Busija DW
Geroscience; 2024 Feb; 46(1):395-415. PubMed ID: 37897653
[TBL] [Abstract][Full Text] [Related]
15. URB597 and Andrographolide Improve Brain Microvascular Endothelial Cell Permeability and Apoptosis by Reducing Oxidative Stress and Inflammation Associated with Activation of Nrf2 Signaling in Oxygen-Glucose Deprivation.
Wang DP; Kang K; Sun J; Lin Q; Lv QL; Hai J
Oxid Med Cell Longev; 2022; 2022():4139330. PubMed ID: 35602108
[TBL] [Abstract][Full Text] [Related]
16. Outgrowth endothelial progenitor cells restore cerebral barrier function following ischaemic damage: The impact of NOX2 inhibition.
Alwjwaj M; Kadir RRA; Bayraktutan U
Eur J Neurosci; 2022 Mar; 55(6):1658-1670. PubMed ID: 35179812
[TBL] [Abstract][Full Text] [Related]
17. Regulation of blood-brain barrier permeability by Salvinorin A via alleviating endoplasmic reticulum stress in brain endothelial cell after ischemia stroke.
Xin J; Ma X; Chen W; Zhou W; Dong H; Wang Z; Ji F
Neurochem Int; 2021 Oct; 149():105093. PubMed ID: 34097989
[TBL] [Abstract][Full Text] [Related]
18. Endothelial Conditional Knockdown of NMMHC IIA (Nonmuscle Myosin Heavy Chain IIA) Attenuates Blood-Brain Barrier Damage During Ischemia-Reperfusion Injury.
Gong S; Cao G; Li F; Chen Z; Pan X; Ma H; Zhang Y; Yu B; Kou J
Stroke; 2021 Mar; 52(3):1053-1064. PubMed ID: 33588591
[TBL] [Abstract][Full Text] [Related]
19. Systolic hypertension-induced neurovascular unit disruption magnifies vascular cognitive impairment in middle-age atherosclerotic LDLr
de Montgolfier O; Pouliot P; Gillis MA; Ferland G; Lesage F; Thorin-Trescases N; Thorin É
Geroscience; 2019 Oct; 41(5):511-532. PubMed ID: 31093829
[TBL] [Abstract][Full Text] [Related]
20. Delay of endothelial cell senescence protects cerebral barrier against age-related dysfunction: role of senolytics and senomorphics.
Ya J; Kadir RRA; Bayraktutan U
Tissue Barriers; 2023 Jul; 11(3):2103353. PubMed ID: 35880392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
